Hoxb8 overexpression immortalises haematopoietic progenitor cells in a growth-factor-dependant manner and co-operates with interleukin-3 (IL-3) to cause acute myeloid leukaemia. To further understand how Hoxb8 contributes to myeloid cell immortalisation, we generated IL-3-dependant myeloid cells expressing Hoxb8 under the control of an inducible promoter. Downregulation of Hoxb8, in the presence of IL-3, caused cell-cycle arrest and apoptosis in the majority of cells. Apoptosis was dependant on Bax and Bak and, in part, on Bim, which was repressed by Hoxb8. Deletion of the miR-17B92 seed sequences in the Bim 3 0 UTR abolished Hoxb8-dependant regulation of Bim reporter constructs. Expression of all six miRNAs from this cluster were elevated when Hoxb8 was overexpressed. The miR-17B92 cluster was required for repression of Bim in Hoxb8-immortalised cells and deletion of the miR-17B92 cluster substantially inhibited Hoxb8, but not Hoxa9, mediated survival and proliferation. Hoxb8 appears to promote miR-17B92 expression through c-Myc, a known transcriptional regulator of the miR-17B92 cluster. We have uncovered a previously unrecognised link between Hoxb8 expression and microRNAs that provides a new insight into the oncogenic functions of Hoxb8.
Hox genes are a family of transcription factors characterised by a conserved homeodomain motif. 1 Hox genes regulate transcription as part of a complex with homeodomaincontaining proteins of the Pre-B cell/CEH-20 family (PBC proteins, Pbx proteins in vertebrates) and the Meis family. 2, 3 Hox genes are critical for the development of body patterning, and several Hox genes from the A and B clusters are important for normal haematopoiesis. 4 For example, transgenic expression of Hoxb4, Hoxb8 or Hoxa9 results in expansion of the haematopoietic stem cell compartment, [5] [6] [7] whereas deletion of Hoxa9 results in leukopaenia as a consequence of stem cell depletion. 8, 9 Deregulated Hox gene expression is linked to leukaemia. Hoxb8, the first Hox gene unequivocally demonstrated to be an oncogene, co-operates with interleukin-3 (IL-3) to cause acute myeloid leukaemia (AML). 6, [10] [11] [12] In human AML, HoxB8 is upregulated as a consequence of overexpression of another homeobox protein, CDX2. 13 Overexpression of Hoxb8 in haematopoietic progenitor cells, in the presence of high concentrations of IL-3, permits the generation of growth factor-dependant myeloid cell lines capable of self-renewal, 6, 14, 15 combining the proliferative signal from IL-3
with the function of Hoxb8 overexpression to block myeloid differentiation. 16, 17 Some evidence suggests that Hox genes capable of immortalising haematopoietic cells, such as Hoxb8, may have additional functions to control apoptosis. For example, AML cell lines harbouring mixed lineage leukaemia (MLL) rearrangements undergo apoptosis when HoxA9 expression is silenced, 18 and Hoxa9-deficient mice have increased lymphocyte apoptosis. 9 In Caenorhabditis elegans, Hox genes regulate the viability of specific neurones by directly regulating the expression of a proapoptotic Bcl-2 family member, EGL-I. 19, 20 Until now, a direct link between Hoxb8 and cell death pathways has not been identified.
We have used a 4-hydroxytamoxifen (4-OHT)-inducible lentiviral expression system to regulate Hoxb8 expression in IL-3-dependant myeloid progenitor cells. In response to Hoxb8 downregulation, cells arrest in the G1 phase of the cell cycle and the fate of most cells was to undergo apoptosis, even in the presence of IL-3. This cell death was absolutely dependant on the Bcl-2-regulatable pathway, because it was completely blocked by deletion of both Bax and Bak. Downregulation of Hoxb8 resulted in elevated Bim expression, which was required for efficient apoptosis after Hoxb8 withdrawal. Hoxb8-dependant regulation of Bim expression required the Bim 3 0 UTR (untranslated region) and, specifically, seed sequences of the miR-17B92 cluster. We show that Hoxb8 expression resulted in higher expression of all microRNAs (miRNAs) from the miR-17B92 cluster. The ability of Hoxb8-immortalised cells (which we refer to as FDM cells for factor-dependant myeloid cells) to clonogenically proliferate was dependant on the presence of at least one allele of miR-17B92. We have gone on to identify a subset of miRNAs that are regulated in a Hoxb8-dependant manner. These findings link, for the first time in mammalian cells, Hox gene expression with the regulation of miRNAs and apoptosis and provide a new insight into the oncogenic functions of Hoxb8.
Results
Hoxb8 overexpression is required to maintain IL-3 FDM cells. We previously generated IL-3-dependant myeloid cell lines using retroviral overexpression of Hoxb8 to study the genes required for apoptosis induced by IL-3 deprivation. 14, 15, 21 To study the response of cells when IL-3 is maintained but Hoxb8 expression is varied, we cloned Hoxb8 into a lentiviral expression system in which expression is induced by 4-OHT. 22 In this system, Hoxb8 is not fused to an estrogen-receptor tag. 23 C-kit-positive, lineage-negative (c-kit þ ve /lin À ve ) haematopoietic progenitor cells (HPC) from C57BL/6 E14.5 embryos were infected with Hoxb8 lentivirus in the presence of 4-OHT and IL-3 to generate IL-3-dependant myeloid progenitor FDM cells. Hoxb8 expression declined to undetectable levels 96 h after 4-OHT removal and re-addition of 4-OHT restored expression of Hoxb8 within 48 h (Figure 1a and Supplementary Figure S1a) . We also used a tetracycline-repressible lentiviral expression system in which Hoxb8 expression was also tightly regulated ( Supplementary Figures S1b and c) .
We tested the requirement for Hoxb8 in immortalisation using colony assays to compare c-kit þ ve /lin À ve progenitors infected with inducible enhanced green fluorescent protein (eGFP) or Hoxb8 (Figure 1b ). Colonies were efficiently generated in the presence of Hoxb8 expression but not in the presence of GFP. The few colonies generated from progenitor cells infected with Hoxb8 in the absence of 4-OHT probably arose as a result of background Hoxb8 expression. Cytokines other than IL-3 could not maintain colony growth in soft agar or viability in liquid culture (Supplementary Figures  S1d and e ). These data demonstrate that c-kit þ ve /lin À ve progenitors immortalised with Hoxb8 in the presence of IL-3 are strictly dependant on both Hoxb8 and IL-3 for survival and proliferation. Following Hoxb8-dependant immortalisation, all FDM clones expressed lineage markers and no longer expressed c-kit. Surface antigen expression remained largely unchanged in the presence or absence of 4-OHT or following the addition of GM-CSF. Some cells expressed higher levels of CD11b and F4/80 after 4-OHT withdrawal (Supplementary Figure S2a) and the morphology of a population of cells altered, changing from small cells with relatively large nuclei (promyelocytes) to larger, non-adherent cells resembling monocytes, with occasional granulocytes (Supplementary Figure S2b) . These data show that Hoxb8 imposes a block on differentiation after commitment to a myeloid lineage, as previously observed, 23 that is released in a proportion of cells when Hoxb8 expression is downregulated.
Reduced Hoxb8 expression caused cells to exit S-phase and accumulate in G1 despite the continued presence of abundant IL-3 in the culture (Figures 1c and d) . Virtually no cells remained in S-phase 6 days after 4-OHT removal. Thus Hoxb8 overexpression was required for continued proliferation in response to IL-3 receptor signalling. This was not a result of diminished expression of the IL-3 receptor components as IL-3 beta common, IL-3-specific beta chain and IL-3 alpha-chain remained detectable after 4-OHT withdrawal (Supplementary Figure S3a and b) and re-addition of 4-OHT was sufficient to initiate re-entry into S-phase of at least a proportion of cells, accompanied by concomitant increase in the number of viable cells (Figures 1c, d and e) . The cell counts in these same cultures showed that cells with uninterrupted Hoxb8 expression steadily increased in number, although a 'plateau' effect was observed when cells required replating at day 6. After 4-OHT was removed, the rate of cell division declined between days 3 and 6, and total cell number fell thereafter. 4-OHT re-addition after 3 days restored proliferation. Together, these data showed that maintenance of Hoxb8 overexpression was required for cells to respond to proliferative signals transduced by IL-3.
Hoxb8 withdrawal activates Bax and Bak-dependant apoptosis pathways. The ultimate fate of most cells after Hoxb8 downregulation was to undergo apoptosis ( Figure 1f) . The decline in cell viability was concomitant with the decline of Hoxb8 to undetectable levels. Cells surviving 4-OHT withdrawal remained IL-3 dependant, eliminating the possibility of selection of IL-3-independent populations (Supplementary Figure S3c) . Moreover, cells could not be rescued from apoptosis by the addition of differentiationassociated cytokines M-CSF or GM-CSF (Supplementary Figure S3d) .
In FDM cells, apoptosis following IL-3 deprivation is regulated by the Bcl-2 family of proteins and is critically dependant on two pro-apoptotic Bcl-2 family members, Bax and Bak. 14, 24 To determine whether apoptosis induced by Hoxb8 downregulation was also regulated by Bcl-2 family proteins, we generated Hoxb8 FDM cells from E13.5 Bax À / À ; Bak À / À HPC. When Bax À / À ;Bak À / À Hoxb8 FDM cells were cultured in the absence of 4-OHT for 9 days, no decline in cell viability was observed (Figure 2a) . Further, apoptosis induced by Hoxb8 downregulation in wild-type FDMs was blocked by the caspase inhibitor Q-VD-Oph (Supplementary Figure S4a) , indicating that a Bax and Bak, caspase-dependant apoptotic pathway was activated by downregulated Hoxb8 expression. We next determined whether regulated Hoxb8 expression was associated with changes in the expression of other Bcl-2 family members. We analysed the protein expression of Bcl-2 family proteins by western blot in wild-type Hoxb8 FDM cells after 4-OHT withdrawal and following 4-OHT re-addition ( Figure 2b and Supplementary Figure S4b) . The most consistent finding, across multiple independently generated lines, was reduced or absent Bim protein expression in the presence of Hoxb8. Thus, independent of the baseline Figure S4e) . Bim expression remained elevated after Hoxb8 restoration over the time course examined, consistent with ongoing apoptosis. Reduced Bim expression was also observed in tetracycline-repressible Hoxb8 FDM cells (Supplementary Figure S4c) . Subtle variations in the expression of other Bcl-2 family members were observed. For example, in some clones, Bmf levels increased, Bcl-xL levels declined and Mcl-1 increased over the time course, even after 4-OHT re-addition (Supplementary Figure S4b) . However, with the exception of Bim, these variations were not consistently observed in all the clones tested. qRT-PCR analysis demonstrated elevated Bim mRNA over a time course of Hoxb8 downregulation (Figure 2c ), indicating that increased Bim protein expression resulted from increased transcription or stability of Bim mRNA.
We tested the requirement for Bim in apoptosis induced by Hoxb8 downregulation using Hoxb8 FDM cells from Bim-deficient mice. 25 Hoxb8 expression was regulated by 4-OHT in Bim À / À Hoxb8 FDM cells as in wild-type cells (Supplementary Figure S4d) . We compared the viability of Bim À / À with wild-type Hoxb8 FDM cells over 9 days following 4-OHT removal (Figure 2d) Hoxb8 FDM cells were cultured in IL-3 without 4-OHT ( À ) or following re-addition of 4-OHT after a 3-day period of withdrawal (re-added). At the indicated time points, cell-cycle analysis was performed using hypotonic PI buffer staining and flow cytometric analysis. The percentage of cells in S-phase was determined using the cell-cycle analysis software ModFit. Results indicate means ± S.E.M. of seven independent clones in three independent experiments. (d) Cells arrest in G1 after Hoxb8 downregulation. Hoxb8 FDM cells were prepared as described in (c) and the percentage of cells in G1 phase was determined using Modfit. Results indicate means ± S.E.M. of seven independent clones in three independent experiments. (e) Hoxb8 expression maintains proliferation in IL-3. Hoxb8 FDM cells were cultured in IL-3 with 4-OHT ( þ ), without 4-OHT ( À ) or following re-addition of 4-OHT after a 3-day period of withdrawal (re-added). At the indicated time points, cell number was counted (see Materials and Methods). Results are means ± S.E.M. of seven independent clones in three independent experiments. (f) Hoxb8 expression maintains viability in IL-3. Cell viability was determined by PI exclusion and FITC-conjugated AnnexinV staining from the same samples as described in (e). Results are means ± S.E.M. of seven independent clones in three independent experiments Hoxb8 regulates microRNAs M Salmanidis et al expression is an important mechanism by which Hoxb8 maintains viable, IL-3-dependant cells. However, as many Bim À / À Hoxb8 FDM cells eventually undergo apoptosis after Hoxb8 downregulation, other Bax and Bak-dependant, Bimindependent apoptosis pathways must also be activated.
Proliferative arrest following Hoxb8 withdrawal is independent of apoptosis. The survival of more Bim À / À Hoxb8 FDM cells showed that Bim À / À FDM cells were slower to enter G1 arrest than wild-type cells, but by day 6 of 4-OHT deprivation, virtually no wild-type or Bim À / À Hoxb8 FDM cells remained in S-phase ( Figure 3b ). These data demonstrate that blocking apoptosis does not result in the accumulation of cells that proliferate independently of Hoxb8 expression. We next determined whether Bax À / À ;Bak À / À and Bim
Hoxb8 FDM cells surviving Hoxb8 downregulation were able to form colonies in soft agar when Hoxb8 expression was restored by replating in soft agar, in the presence of abundant IL-3 and 4-OHT ( Figure 3c ). The number of colonies generated after restoration of Hoxb8 expression steadily declined over time in all clones tested. Deletion of Bim or of both Bax and Bak offered no advantage in colony formation. In fact, some Bim À / À Hoxb8 FDM clones had a lower relative clonogenicity than wild-type or Bax À / À ; Bak À / À Hoxb8 FDM clones 3 days after 4-OHT withdrawal. These data indicate that the function of Hoxb8 to maintain cell viability and self-renewal can be separated genetically. Maintaining cell viability after Hoxb8 downregulation is not equivalent to accumulating cells capable of continued selfrenewal. Our data suggest that the subpopulation of cells that retain the capacity for clonogenic proliferation is not expanded in vitro by blocking intrinsic apoptosis pathways.
Hoxb8-dependant regulation of Bim expression requires the Bim 3
0 UTR. Our data suggested that Bim is a target of a Hoxb8-dependant gene repression mechanism. To define the region of the Bim gene required for Hoxb8-dependant repression, we used luciferase reporter constructs that encoded 3.6 kB of the murine Bim promoter region upstream of Exon 1, the first intron of Bim and the 3 0 UTR of Bim. These constructs were transiently transfected into 293T cells stably overexpressing GFP or Hoxb8. Expression of Hoxb8 halved luciferase activity only in cells expressing the Bim 3 0 UTR construct (Figure 4a ). This result suggested that Hoxb8- 
26-29
To determine whether any miRNAs predicted to bind the Bim 3 0 UTR were also regulated in a Hoxb8-dependant manner, we profiled the changes in expression levels of all murine miRNAs after Hoxb8 withdrawal by qPCR arrays (Figure 4b ). Most notable among the miRNAs expressed in the presence of Hoxb8 were all members of the miR-17B92 cluster, miR-17, miR-18, miR-19a, miR-20, miR-19b and miR-92 ( Figure 4c ). This significant upregulation of all members of the cluster strongly suggests that Hoxb8 transcriptionally regulates the cluster. Of the various miRNAs induced by Hoxb8, miR-17, miR-19a/b, miR-92, miR-214 and miR-9 are predicted by Targetscan (http://www.targetscan.org/) to target the Bim 3 0 UTR, although miR-9 is given an exceedingly low ranking. 30, 31 To determine the region of the Bim 3 0 UTR required for Hoxb8-dependant repression, we used a GFP reporter system in which GFP is fused to the regions of murine Bim 3 0 UTR extending from the stop codon for 4217 bases (corresponding to chr2:127,984,066-127,988,283). The reporter constructs contain several predicted miR-17B92 cluster binding sites. Reporter plasmids were infected into 293T cells stably expressing Hoxb8 and flow cytometry used to measure mean GFP fluorescence intensity relative to cells expressing a reporter containing GFP alone (Figure 5a ). Hoxb8 overexpression decreased GFP expression in cells transfected with the Bim 3 0 UTR reporter construct retaining binding sites for miR-17 as well as miR-19a/b and miR-92. No change in GFP expression was observed in cells expressing reporter constructs with other segments of the 3 0 UTR. This data, together with the changes of miRNA expression observed after downregulation of Hoxb8, supports the conclusion that miRNAs from the miR-17B92 cluster, in particular miR-17, miR-19a/b and miR-92, mediate Hoxb8-dependant repression of Bim.
We independently validated the changes in miR-17B92 expression observed after Hoxb8 downregulation. We measured the abundance of mature miRNAs from this cluster in the presence or absence of induced Hoxb8 expression in independent Hoxb8 FDM cell lines using Taqman microRNA assays. As observed in the qPCR array, the expression of miR-17-5p, miR-19a-3p, miR-19b-3p and miR-92-3p decreased significantly after 4-OHT withdrawal (Figure 5b) . No decrease in miR-17-3p and miR-18a-5p was observed, with miR-17-3p being at almost undetectable levels. miR-18a-5p expression remained stable.
We then determined whether other predicted targets of the miR-17B92 cluster were also differentially expressed in the presence and absence of Hoxb8. Cyclin-dependant kinase inhibitor 21 is described as regulated by the miR-17B92 cluster and PTEN expression is repressed by miR-17-5p and miR-19 (ref [32] [33] [34] . Western blots of lysates from three independent Hoxb8 FDM clones cultured in the presence or absence of 4-OHT were probed with antibodies against Bim, p21 and the phosphatase PTEN (Figure 5c ). The baseline expression of Bim varied from clone to clone, but as we have observed in numerous independent clones and again in these, reduced Hoxb8 expression is always associated with elevated Bim expression. We observed variation in p21 expression across the three lines, with a subtle increase in p21 expression in the absence of Hoxb8 in two of three lines. This may reflect the proportion of cells within each clone that have recently entered G1 arrest, which we have previously observed is associated with transient p21 expression in these cells. 35 PTEN expression was consistently reduced in all the three clones after Hoxb8 expression was downregulated ( Figure 5c ). As miR-17-5p and miR-19a/b expression levels decline after Hoxb8 withdrawal, the diminished expression of PTEN is probably independent of the miR-17B92 cluster. The data suggest that the principal putative miR-17B92 target that is repressed in these cells is Bim. Hoxb8 regulates microRNAs M Salmanidis et al miR-17B92 cluster following cre-recombinase expression. 29 We utilised miR-17B92 flx/flx constitutive Hoxb8 FDM cell lines and included FDMs immortalised with Hoxa9 as a control. We reasoned that if Hoxb8 did not require miR-17B92, deletion of the cluster would have no effect on Hoxb8-dependant immortalisation. miR-17B92 flx/flx Hoxb8 and Hoxa9 FDM cells were cultured in semi-solid agar after infection with cre-recombinase lentivirus and the number of colonies counted after 14 days. Both Hoxb8 and Hoxa9 miR-17B92 flx/flx FDM cells formed colonies after cre-recombinase expression (Figure 6a) , despite an anticipated cre-recombinase-associated reduction in colony formation. Random colonies were selected from all independent experiments and genotyped to establish deletion of miR-17B92 alleles. We found that 85% of miR-17B92 flx/flx Hoxb8 colonies retained at least one miR-17B92 allele while 50% of Hoxa9-immortalised miR-17B92 flx/flx colonies had deleted both alleles (Figure 6b ). This result established that while colonies could be generated from miR-17B92 flx/flx cells, a strong selection bias against deletion of miR-17B92 was evident in Hoxb8 FDM cells. mmu-miR-211-5p mmu-miR-381-3p mmu-miR-467d-5p mmu-miR-687 mmu-miR-881-5p mmu-miR-692 mmu-miR-150-5p mmu-miR-155-5p mmu-miR-146b-3p mmu-miR-146b-5p mmu-miR-22-3p mmu-miR-409-3p mmu-miR-330-5p mmu-miR-331-3p mmu-miR-29c-5p mmu-miR-223-3p mmu-miR-466j mmu-miR-27a-5p mmu-miR-22-5p mmu-miR-501-3p mmu-miR-2135 mmu-miR-674-3p mmu-miR-1901 mmu-miR-744-5p mmu-miR-2182 mmu-miR-1937b mmu-miR-1937c mmu-miR-500-3p mmu-miR-365-3p mmu-miR-24-2-5p mmu-miR-2138 mmu-miR-24-3p mmu-miR-744-3p mmu-miR-339-3p mmu-miR-664-3p mmu-miR-532-3p mmu-miR-1839-3p mmu-miR-let-7a-5p mmu-miR-18a-3p mmu-miR-19b-3p mmu-miR-19a-3p mmu-miR-18a-5p mmu-miR-696 mmu-miR-17-3p mmu-miR-25-3p mmu-miR-106a-5p mmu-miR-20a-5p mmu-miR-106b-3p mmu-miR-17-5p mmu-miR-138-5p mmu-miR-1306-3p mmu-miR-320-3p mmu-miR-15b-5p mmu-miR-200b-3p mmu-miR-15a-3p mmu-miR-92a-3p mmu-miR-378-5p mmu-miR-9-5p mmu-miR-805 mmu-miR-181a-5p mmu-miR-26b-5p mmu-miR-345-3p mmu-miR-26b-3p mmu-miR-187-3p mmu-miR-741-3p mmu-miR-214-3p mmu-miR-450b-5p b) that are members of the miR-17B92 cluster on chromosome 13 and related genes on chromosomes 7 and X. P-values of fold changes were calculated using a Student's t-test (independent, two-tailed). Indicated are both the -5p and -3p strands of each miRNA corresponding to the fold change observed for each in the qPCR array. This includes miRNAs previously known as the star forms
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To explore the possibility that deletion of the miR-17B92 cluster in Hoxb8 FDMs resulted in increased levels of Bim, western blots of miR-17B92 À / À Hoxb8 FDM cells before and after treatment with cre-recombinase were probed with antibodies against Bim and cre-recombinase. The crerecombinase-induced deletion of the miR-17B92 cluster resulted in an increase in Bim expression which was not observed when cre-recombinase was expressed in WT cells or when GFP was expressed in miR-17B92 flx/flx cells (Figure 6c ). This result clearly indicates that Bim repression by Hoxb8 is mediated by the miR-17B92 cluster.
Upregulated expression of miR-17B92 may be a direct or indirect consequence of Hoxb8 expression. A region 2 kB upstream of the transcriptional start site of the MIR17HG locus contains a putative Hox binding site. We therefore immortalised progenitor cells with a Flag-tagged Hoxb8 construct and performed a chromatin immunoprecipitation (ChIP)-PCR experiment to detect any direct binding of Hoxb8 within the miR-17B92 promoter (Supplementary Figure S5a  and b) . We selected primers that covered the main promoter regions of MIR17HG, as well as regions up-and downstream. We found no significant enrichment for Hoxb8 binding above that observed for beta-actin, a negative control. This strongly suggests Hoxb8 does not bind within the promoter region of MIR17HG. The best described transcriptional regulator of the miR-17B92 cluster is c-Myc. 36 We speculated that Hoxb8 expression may be associated with c-Myc expression. We used western blotting to visualise c-Myc expression levels in three independently derived Hoxb8 FDM cell lines in the presence or absence of 4-OHT (to regulate Hoxb8 expression). In each clone, we observed a reduction in c-Myc expression when Hoxb8 expression declined (Figure 6d ). These data support the hypothesis that miR-17B92 expression, in the presence of Hoxb8, is a consequence of c-Myc expression. The mechanism by which Hoxb8 maintains c-Myc levels remains to be determined.
Discussion
Hoxb8 was the first Hox gene demonstrated to function as an oncogene, contributing to the development of AML. 6, 10, 12 When overexpressed, Hoxb8, like other oncogenic Hox genes, imposes a block on differentiation. However, the molecular targets regulated by Hoxb8 remain largely Here we show that an additional critical role of Hoxb8 overexpression is suppression of apoptosis, achieved in part by repression of Bim. Furthermore, we have identified the miR-17B92 cluster as a mediator of Hoxb8-dependant Bim repression. Our data strongly suggest that a larger subset of miRNAs are also involved in the block to differentiation and apoptosis imposed by Hoxb8 overexpression and the response when that block is released. The link between Hoxb8 and miR-17B92 expression has not previously been described. Hoxb8 and paralogues Hoxa7, Hoxc8 and Hoxd8 are themselves regulated by the miR-196 miRNAs. 37 However, the concept that some or all of the oncogenic functions of Hoxb8 might be mediated through the expression of other miRNAs is a novel finding for which, to our knowledge, no precedent exists. miR-17-92 is a polycistronic miRNA cluster located in the human genome at chromosome 13q31.3. The cluster contains six mature miRNAs, miR-17, miR-18a, miR-19a, miR-20a, miR-19b and miR-92. Strong evidence supports the oncogenic effects of overexpression of miR-17B92. Genomic amplification and elevated expression of miR-17B92 expression is recognised in several tumour types, including diffuse large B-cell lymphoma, 38 Mantle Cell Lymphoma 39 and several types of solid tumours. 40, 41 In the absence of copy number changes, other transcription factors, notably c-Myc, directly upregulate miR-17B92 expression. 36 Co-expression of c-Myc and miR-17B92 cooperate to promote lymphomagenesis. 42 In the absence of any direct binding by Hoxb8 in the miR-17B92 genomic locus, we observed a correlation between Hoxb8 expression, miR-17B92 elevation and c-Myc expression. This suggests a pathway in which c-Myc, expressed at elevated level in the presence of Hoxb8, drives expression of miR-17B92. The mechanism by which Hoxb8 maintains c-Myc levels remains to be determined. Our success in immunoprecipitating Hoxb8 under ChIP conditions makes it now possible to undertake a ChIP-Seq approach to identify bona fide Hoxb8 targets, including miRNA genes and possibly c-Myc.
Our data shows that Hoxb8 specifically requires miR-17B92 to repress Bim expression and efficiently maintain the survival and proliferation of hematopoietic cells. This requirement was evident in the strong selection against deletion of miR-17B92 in Hoxb8-immortalised FDM cells and suggests that elevated miR-17B92 expression, driven by Hoxb8, is an important mechanism of Hoxb8 oncogenic activity. This may also be true of other Hox genes, as half the Hoxa9-immortalised colonies from miR-17B92 flx/flx FDM cells also retained at least one miR-17B92 allele. This is supported by observations that rearrangements of the MLL locus cause AML that is dependant on endogenous Hoxa9 (ref 43, 44) and that leukaemic stem cells from MLLassociated leukaemias express higher levels of miR-17B92 than normal progenitor cells. 32 However, our data also clearly show that miR-17B92 is not absolutely required for Hoxa9-dependant immortalisation.
Bim deletion protected cells from apoptosis after downregulation of Hoxb8, showing that repression of Bim expression is one mechanism by which Hoxb8 maintains cell viability. Bim is required for normal haematopoiesis and deletion of Bim results in leukocytosis and diminished apoptosis in response to a range of stimuli. 25 It is well established that Bim mRNA is regulated by miR-17B92. It is tempting to conclude that Bim regulation by Hoxb8 is a key molecular mechanism underpinning Hoxb8 onocgenic function, as both deletion of Bim and enforced expression of miR17B92 can drive the generation of lymphoma and lymphoproliferative disease. 42, 45, 46 However, deletion of Bim (or Bax and Bak) was not sufficient to promote clonogenic survival or growth-factor-independent proliferation in our experiments. In contrast, deletion of miR-17B92 significantly diminished the capacity of Hoxb8 to maintain clonogenic potential, indicating that miR-17B92-regulated targets other than Bim are equally, if not more, important in Hoxb8-dependant immortalisation. Although other published data suggest these targets include p21 or PTEN (ref [32] [33] [34] 36, 47) , our data do not support the hypothesis that p21 or PTEN are directly regulated by Hoxb8 in our cells. Full characterisation of bone fide miRNA target mRNAs remains a considerable experimental challenge. 48 Other approaches, which capture and sequence mRNAs in complex with the RNAi-induced silencing complex, may provide a more robust approach.
We have identified that the ability of Hoxb8 overexpression to maintain viability and proliferation of haematopoietic progenitor cells relies crucially on the capacity of Hoxb8 to maintain miR-17B92 expression, and for this miRNA cluster to regulate critical targets that include Bim. The regulation of miR-17B92 and other miRNAs in a Hoxb8-dependant manner provides a novel insight into the oncogenic functions of Hoxb8 and identifies a subset of miRNAs that may crucially regulate the block in differentiation and maintenance of self-renewal potential that contribute to leukaemiagenesis. Identification of other key targets regulated by miR-17B92 and other miRNAs in our model may provide the necessary means to specifically target critical deregulated pathways in these malignancies.
Materials and Methods
Cloning. The mouse Hoxb8 cDNA was amplified using PCR from pET Hoxb8 HIS-tag kana and cloned into the 4-OHT inducible, pF 5xUAS eGFP SV40 puro GEV16 lentiviral plasmid 49 and the doxycycline repressible, pF 7xTetOP GSlinker RS PGK Hygro TetRVP16 lentiviral plasmid as described in Supplementary  Materials and Methods and Supplementary Tables 1 and 2 . Both plasmids were kind gifts from Dr. John Silke (Walter and Eliza Hall Institute, Parkville, VIC, Australia). Constitutive expression of Hoxb8 as well as Hoxa9 was achieved by cloning Hoxb8 or HoxA9 into the lentiviral vector, pFU SV40 puro W. Crerecombinase was also cloned into this vector system. The Bim 3.6 kB promoter region upstream of Exon 1 as well as full-length Intron 1 were cloned into the pGL2 basic plasmid using restriction enzyme sites HindII and KpnI while the Bim 3 0 UTR was cloned into the pGL3 promoter plasmid using restriction enzyme sites SpeI and BamHI. All plasmids were a kind gift from Hamsa Puthalakath (LaTrobe University, Melbourne, VIC, Australia). The various Bim 3 0 UTR segments were cloned into the FUGW lentiviral plasmid using an EcoRI/ EcoRI site. All constructs were a kind gift from Dr. Marco Herold (Walter and Eliza Hall Institute).
Constitutive cre-recombinase was expressed using the pFU cre PGK Hygro W plasmid, a kind gift from Dr. John Silke (Walter and Eliza Hall Institute). Doxycycline inducible cre-recombinase expression was achieved using the pFTREtight MCS rtTAadvanced GFP lentiviral vector (Kahn, Okamoto and Huang-manuscript in preparation). Cre-recombinase was digested from the pFU cre-PGK Hygro W plasmid using BamHI/NheI and ligated into the BamHI/NheI digested pFTREtight MCS rtTAadvanced GFP lentiviral vector. Successful ligation was confirmed by diagnostic digest.
Mice. All wild-type cell lines were derived from C57BL/6 E14.5 embryos. The Bim À / À , Bax À / À ; Bak À / À and miR-17B92 flx/flx mice have been previously described. 25, 29, 50 Hoxb8 FDM cell line generation. IL-3-dependant Hoxb8 FDM cells were generated by isolating c-kit-positive, lineage-negative, haematopoietic progenitors from E14.5 fetal livers by flow cytometry using an antibody cocktail mix of c-kit-APC, Gr-1-FITC, NK1.1-FITC, B220-FITC and TER-119-FITC (All from BD Pharmingen, North Ryde, NSW, Australia). Cells were infected via spinoculation with 4-OHT-inducible or doxycycline-repressible Hoxb8 lentivirus and 5 mg/ml polybrene at 30 1C for 90 min at 2500 r.p.m. 4-OHT-inducible cell lines were selected with 0.5 mg/ml of puromycin (Sigma-Aldrich, St. Louis, MO, USA) for 10 days while doxycycline-repressible cell lines were selected with 200 mg/ml of hygromycin (Roche, Dee Why, NSW, Australia) for 14 days. After selection, 4-OHT-inducible cell lines were continuously maintained in low glucose DMEM supplemented with 10% fetal calf serum, 0.25 ng/ml IL-3 (R&D Systems, Minneapolis, MN, USA) and 0.1 mM 4-OHT (Sigma-Aldrich) to induce Hoxb8 expression. Doxycycline-repressible cell lines were cultured as per 4-OHTinducible cell lines, however, in the absence of 4-OHT. Repression was achieved with 0.5 mg/ml of doxycycline (Sigma-Aldrich). Individual clones were selected using soft agar cloning as previously described. 15 without 0.1 mM 4-OHT. Growth supplements were replenished by adding 100 ml of DMEM plus 10% FCS, 0.25 ng/ml IL-3 and 0.1 mM 4-OHT if cells were initially sorted with 4-OHT. After 14 days, the number of colonies were counted.
For clonogenic assays in soft agar culture, cells were washed three times in PBS to remove 4-OHT and known numbers of cells were replated into a soft agar master mix with DMEM, 20% FCS and 0.3% Agar. 4-OHT was used at 0.1 mM and IL-3 at 0.3 ng/ml if required in soft agar.
Luciferase reporter assays. 10 5 293T cells were transfected using the Effectene Transfection Kit (Qiagen) with 1.5 mg of firefly luciferase plasmid and 0.5 mg of renilla luciferase plasmid. Twenty-four hours after transfection, culture medium was replaced. Seventy-two hours after initial transfection, cells were lysed and analysed on a FLUOstar Optima (BMG Labtechnologies, Ortenberg, Germany) using the Dual Luciferase Reporter Assay System (Promega, Auburn, VIC, Australia).
miRNA PCR array. A total of 300 ng of total RNA extracted using Trizol was reverse transcribed using TaqMan MicroRNA Reverse Transcription Kit (Applied Biosystems, Mulgrave, VIC, Australia) and Megaplex RT Primers, Rodent Pool A and Pool B v3.0 (Applied Biosystems, Australia). cDNA was then pre-amplified using Taqman PreAmp Master Mix (Applied Biosystems, Australia) and Megaplex PreAmp Primers, Rodent Pool A nd Pool B v3.0 (Applied Biosystems, Australia). Amplified Product was then loaded onto Taqman Array Rodent v3.0 miRNA (A þ B) cards (Applied Biosystems, Australia) and PCR performed on the 7900-HT real-time PCR system (Applied Biosystems, Australia). The array cards contain Taqman assays for 641 unique mouse miRNAs. Ct values were extracted for each miRNA using RQ Manager software (Applied Biosystems, Australia). miRNA data were expressed as dCT relative to U6snRNA and then normalised between samples based on global miRNA expression of the 50% highest expressing miRNAs. miRNAs with primary expression of Ct435 and differential miRNA expression of 41.5-fold with P values r0.05 (Student's t-test, two-tailed, independent) were considered to be significant. Fold change is the DDCt of the difference in the average normalised DCt across three biological samples for both þ 4-OHT and À 4-OHT.
miRNA qRT-PCR. RNA from 5 Â 10 6 cells was extracted using Trizol (Sigma-Aldrich). In all, 10 ng of RNA was reverse transcribed as per the manufacture's instructions using a Taqman miRNA Reverse Transcription Kit (Applied Biosystems, Australia) with the RT-specific primers for age-miR-17-3p, age-miR-17-5p, hsa-miR-16-5p, hsa-miR-20a-5p, hsa-miR-19b-3p, hsa-miR-92a-3p, age-miR-18, hsa-miR-19a-3p and U6 snRNA (all from Applied Biosystems, Australia). miRNA levels were quantitated using the Taqman Small RNA assay kit (Applied Biosystems, Australia) with miRNA-specific primers as per the manufacture's instructions. qPCR was performed using the Viia7 Real-Time PCR system (Applied Biosystems, Australia). U6 were used for normalisation.
